in

Providers, insurers and pharma play blame game on Wegovy shortage

Digital mental health startups scramble as in-person visit rule looms

Telehealth companies, health insurers and pharmaceutical manufacturers are playing the blame game amid a shortage of popular weight loss drugs. 

Wegovy manufacturer Novo Nordisk said in May shortages of certain doses of the weight loss drug are expected to persist through September. The shortage of weight loss medications known as glucagon-like peptide agnostics, or GLP-1s, also includes Novo Nordisk’s diabetes drug Ozempic and Eli…


Posted by Editor

Masterclass | The Complete Playbook for Generative AI in Fashion

Masterclass | The Complete Playbook for Generative AI in Fashion

The Best Phones Under Rs. 15,000 You Can Buy In India